BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Talos Energy
TALO
$2.58B
| $26.3M | ﹤0.01% |
2,862,125
-355,259
| -11% | -$3.7M |
|
2652
Precision BioSciences
DTIL
$201M
| $26.3M | ﹤0.01% |
105,080
+24,003
| +30% | +$5.26M |
|
2653
Team
TISI
$101M
| $26.3M | ﹤0.01% |
471,380
+2,993
| +0.6% | +$165K |
|
|
FMTX
2654
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $26M | ﹤0.01% |
+559,852
| New | +$24.3M |
|
2655
Daktronics
DAKT
$988M
| $26M | ﹤0.01% |
5,973,446
-165,608
| -3% | -$732K |
|
|
AMRN
2656
Amarin Corp
AMRN
$299M
| $26M | ﹤0.01% |
187,705
+32,564
| +21% | +$4.48M |
|
|
FFIC
2657
DELISTED
Flushing Financial
FFIC
| $26M | ﹤0.01% |
2,253,568
+52,204
| +2% | +$597K |
|
|
HAPN
2658
Happen Inc
HAPN
$2.27B
| $25.9M | ﹤0.01% |
5,701,860
+69,301
| +1% | +$431K |
|
|
CDMO
2659
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $25.9M | ﹤0.01% |
3,945,988
+64,467
| +2% | +$360K |
|
2660
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $25.9M | ﹤0.01% |
667,730
-67,590
| -9% | -$2.47M |
|
2661
Grupo Cibest SA
CIB
$22.7B
| $25.9M | ﹤0.01% |
983,785
-1,735,109
| -64% | -$45.5M |
|
2662
Harmony Gold Mining
HMY
$12B
| $25.9M | ﹤0.01% |
6,200,487
+1,248,086
| +25% | +$4.11M |
|
|
AKRO
2663
DELISTED
Akero Therapeutics
AKRO
| $25.7M | ﹤0.01% |
1,029,982
+309,868
| +43% | +$7.08M |
|
|
MEET
2664
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $25.6M | ﹤0.01% |
4,094,934
-518,411
| -11% | -$3.19M |
|
2665
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
| $25.5M | ﹤0.01% |
868,617
-9,919
| -1% | -$277K |
|
2666
Bar Harbor Bankshares
BHB
$681M
| $25.5M | ﹤0.01% |
1,139,213
+64,347
| +6% | +$1.2M |
|
2667
CALL
Boston Scientific
BSX
$74.9B
| $25.4M | ﹤0.01% |
724,700
-21,900
| -3% | -$789K |
|
|
VNET
2668
VNET Group
VNET
$2.12B
| $25.4M | ﹤0.01% |
1,066,267
-218,795
| -17% | -$3.53M |
|
2669
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
| $25.4M | ﹤0.01% |
541,852
-234,989
| -30% | -$11.1M |
|
|
CHS
2670
DELISTED
Chicos FAS, Inc.
CHS
| $25.4M | ﹤0.01% |
18,412,168
+83,713
| +0.5% | +$114K |
|
|
BPYU
2671
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $25.4M | ﹤0.01% |
2,547,379
-209,811
| -8% | -$2.11M |
|
2672
Metallus
MTUS
$892M
| $25.4M | ﹤0.01% |
6,518,213
+69,538
| +1% | +$232K |
|
|
TDAY
2673
USA Today Co
TDAY
$1B
| $25.3M | ﹤0.01% |
18,357,206
-1,292,487
| -7% | -$1.7M |
|
2674
MasterCraft Boat Holdings
MCFT
$598M
| $25.3M | ﹤0.01% |
1,327,949
+11,862
| +0.9% | +$149K |
|
2675
First Mid Bancshares
FMBH
$1.39B
| $25.2M | ﹤0.01% |
962,013
+27,214
| +3% | +$682K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.